[ELOC-mutated renal cell carcinoma with new mutation site combined with lung adenocarcinoma: report of a case].

Chen, X Q; Huang, J; Lan, Y; Wu, Y L; Yan, X C; Bian, X W; Duan, G J

Chen, X Q; Huang, J; Lan, Y; Wu, Y L; Yan, X C; Bian, X W; Duan, G J.

Affiliation

Chen XQ; Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Huang J; Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Lan Y; Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Wu YL; Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Yan XC; Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Bian XW; Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Duan GJ; Department of Pathology, the First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.

Zhonghua Bing Li Xue Za Zhi ; 53(8): 861-863, 2024 Aug 08.

Article in Zh | MEDLINE | ID: mdl-39103273

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Adenocarcinoma of Lung / Kidney Neoplasms / Lung Neoplasms / Mutation Limits: Humans / Male Language: Zh Journal: Zhonghua Bing Li Xue Za Zhi Year: 2024 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google